comprehensive -WSS

comprehensive

author：fashion 2025-10-02 17:27:31 - browse：5882

ASH19 CAR-T — Victor Segura Ibarra and Rita Serda, Ph.D., NCI, NIH

The Food and Drug Administration on Wednesday approved a futuristic new approach to treating cancer, clearing a Novartis therapy that has produced unprecedented results in patients with a rare and deadly cancer. The price tag: $475,000 for a course of treatment.

That sounds staggering to many patients — but it’s far less than analysts expected.

The therapy, called a CAR-T, is made by harvesting patients’ white blood cells and rewiring them to home in on tumors. Novartis’s product is the first CAR-T therapy to come before the FDA, leading a pack of novel treatments that promise to change the standard of care for certain aggressive blood cancers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Johnson & Johnson sued for allegedly overpaying for workers' drugs

Wikipedia

WSS

Unique patient identifier: Experts argue the benefits, pitfalls

A protest over insulin prices is seen as a fight for life

Readout Newsletter: Amgen, Regeneron, BGI Group and more

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

Why an extreme heat and wildfire smoke combination can be so dangerous

hotspot

comprehensive

entertainment

United colonoscopy coverage change 'may cost lives,' doctors say

Devoted Health’s losses in Medicare Advantage persist

Trump demands the U.S. pay no more for drugs than other countries … again

Will.i.am, Britney Spears release new single, 'Mind Your Business'

Wildfire smoke exposes gaps in outdoor worker protections

Gene therapy for Afghan refugees’ infant will be fully covered

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Marvel Studios reveals new trailer for 'The Marvels': Watch here

Medicare proposal to cover medical devices draws a mixed reaction

CDC backtracks, saying fully vaccinated people can go maskless indoors

focus

Top private equity targets in 2023: cardiology, clinical trials, lasers

Review: 'Barbie' will hit you like a shot in the heart

Will.i.am, Britney Spears release new single, 'Mind Your Business'

FDA official pushes for dedicated emerging pathogens team

Medicare Advantage plans can’t deny care with AI, CMS warns

Artificial intelligence advances fuel industry trying to preserve loved ones after death

focus

Wikipedia

focus

Wikipedia